ANGN
Income statement / Annual
Last year (2022), Angion Biomedica Corp.'s total revenue was $2.30 M,
a decrease of 91.87% from the previous year.
In 2022, Angion Biomedica Corp.'s net income was -$55.70 M.
See Angion Biomedica Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2013
|
FY-2012
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2013 |
12/31/2012 |
| Operating Revenue |
$2.30 M
|
$28.31 M
|
$2.88 M
|
$1.49 M
|
$4.03 M
|
$6.58 M
|
$7.30 M
|
| Cost of Revenue |
$0.00 |
$433,000.00 |
$1.19 M |
$640,000.00 |
$378,000.00 |
$3.17 M |
$3.67 M |
| Gross Profit |
$2.30 M |
$27.88 M |
$1.69 M |
$847,000.00 |
$3.65 M |
$3.41 M |
$3.62 M |
| Gross Profit Ratio |
1 |
0.98 |
0.59 |
0.57 |
0.91 |
0.52 |
0.5 |
| Research and Development
Expenses |
$18.10 M
|
$48.70 M
|
$38.98 M
|
$29.84 M
|
$12.60 M
|
$196,008.00
|
$0.00
|
| General & Administrative
Expenses |
$14.64 M
|
$18.49 M
|
$17.99 M
|
$9.60 M
|
$5.39 M
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$14.64 M
|
$18.49 M
|
$17.99 M
|
$9.60 M
|
$5.39 M
|
$0.00
|
$0.00
|
| Other Expenses |
$9.19 M |
-$15.27 M |
-$24.83 M |
-$583,000.00 |
$0.00 |
$3.61 M |
$4.04 M |
| Operating Expenses |
$32.74 M |
$67.19 M |
$56.96 M |
$39.44 M |
$17.99 M |
$3.81 M |
$4.04 M |
| Cost And Expenses |
$32.74 M |
$67.62 M |
$58.15 M |
$40.08 M |
$18.37 M |
$6.98 M |
$7.72 M |
| Interest Income |
$0.00 |
$0.00 |
$0.00 |
$265,000.00 |
$252,000.00 |
$0.00 |
$0.00 |
| Interest Expense |
$805,000.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$300,432.00 |
$307,450.00 |
| Depreciation &
Amortization |
$10.32 M
|
$801,000.00
|
$628,000.00
|
$2.47 M
|
$2,000.00
|
$460,344.00
|
$463,216.00
|
| EBITDA |
-$20.12 M
|
-$39.31 M
|
-$55.27 M
|
-$36.12 M
|
-$20.02 M
|
$1.85 M
|
$1.28 M
|
| EBITDA Ratio |
-8.74 |
-1.39 |
-19.19 |
-24.29 |
-4.97 |
0.28 |
0.18 |
| Operating Income Ratio
|
-13.23
|
-1.39
|
-19.19
|
-25.95
|
-3.56
|
-0.06
|
-0.06
|
| Total Other
Income/Expenses Net |
-$8.37 M
|
-$15.27 M
|
-$24.83 M
|
-$2.07 M
|
-$5.68 M
|
$2.13 M
|
$1.61 M
|
| Income Before Tax |
-$38.81 M |
-$54.57 M |
-$80.11 M |
-$40.66 M |
-$20.03 M |
$1.73 M |
$1.19 M |
| Income Before Tax Ratio
|
-16.87
|
-1.93
|
-27.81
|
-27.34
|
-4.97
|
0.26
|
0.16
|
| Income Tax Expense |
$16.89 M |
-$801,000.00 |
-$628,000.00 |
$1.71 M |
-$5.68 M |
$452,778.00 |
$201,858.00 |
| Net Income |
-$55.70 M |
-$53.77 M |
-$79.48 M |
-$42.37 M |
-$20.03 M |
$632,241.00 |
$307,303.00 |
| Net Income Ratio |
-24.21 |
-1.9 |
-27.6 |
-28.49 |
-4.97 |
0.1 |
0.04 |
| EPS |
-1.85 |
-1.9 |
-2.76 |
-2.51 |
-1.3 |
0.0374 |
0.0182 |
| EPS Diluted |
-1.85 |
-1.9 |
-2.76 |
-2.51 |
-1.3 |
0.0374 |
0.0182 |
| Weighted Average Shares
Out |
$30.04 M
|
$28.24 M
|
$28.78 M
|
$16.90 M
|
$15.36 M
|
$16.90 M
|
$16.90 M
|
| Weighted Average Shares
Out Diluted |
$30.04 M
|
$28.24 M
|
$28.78 M
|
$16.90 M
|
$15.36 M
|
$16.90 M
|
$16.90 M
|
| Link |
|
|
|
|
|
|
|
